Back to
MILLER VALUE PARTNERS, LLCWEWEK
WEWEKShowing 0 of 12 quarters
Position history for
MILLER VALUE PARTNERS, LLC's holdings in ZIOPHARM ONCOLOGY INC
No. Miller Value Partners exited its WEK (Ziopharm Oncology) position in Q3 2021. Its Q2 2021 13F listed 10,317,698 shares worth $27.2M. Miller Value Partners already held WEK in its Q4 2018 13F, the earliest on record, and held it in 11 quarterly 13F filings.
Current Value
-
Current Shares
-
Total Value Change
$0
Total Shares Change
0
No position history available for this security.
Other major holders of WEK: MSD Partners, L.P., STATE STREET CORP